Atlas Trials

ANTIcoagulation in Severe COVID-19 Patients

Clinical trial NCT04808882 · COMPLETED

Trial details

NCT number
NCT04808882
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe COVID-19 Pneumonia
Start date
2021-04-14
Primary completion
2022-01-10
Enrollment
353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.